List of Tables
Table 1. Global Therapeutic Peptide APIs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Therapeutic Peptide APIs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Therapeutic Peptide APIs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Therapeutic Peptide APIs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Therapeutic Peptide APIs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Therapeutic Peptide APIs Sales by Region (2020-2025) & (Tons)
Table 8. Global Therapeutic Peptide APIs Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Therapeutic Peptide APIs Sales by Manufacturers (2020-2025) & (Tons)
Table 11. Global Therapeutic Peptide APIs Sales Share by Manufacturers (2020-2025)
Table 12. Global Therapeutic Peptide APIs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Therapeutic Peptide APIs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Peptide APIs as of 2024)
Table 16. Global Therapeutic Peptide APIs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Therapeutic Peptide APIs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 18. Key Manufacturers Therapeutic Peptide APIs Manufacturing Base and Headquarters
Table 19. Global Therapeutic Peptide APIs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Therapeutic Peptide APIs Sales by Type (2020-2025) & (Tons)
Table 23. Global Therapeutic Peptide APIs Sales by Type (2026-2031) & (Tons)
Table 24. Global Therapeutic Peptide APIs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Therapeutic Peptide APIs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Therapeutic Peptide APIs ASP by Type (2020-2031) & (US$/kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Therapeutic Peptide APIs Sales by Application (2020-2025) & (Tons)
Table 29. Global Therapeutic Peptide APIs Sales by Application (2026-2031) & (Tons)
Table 30. Therapeutic Peptide APIs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Therapeutic Peptide APIs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Therapeutic Peptide APIs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Therapeutic Peptide APIs ASP by Application (2020-2031) & (US$/kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Therapeutic Peptide APIs Growth Accelerators and Market Barriers
Table 37. North America Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Therapeutic Peptide APIs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Therapeutic Peptide APIs Growth Accelerators and Market Barriers
Table 40. Europe Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Therapeutic Peptide APIs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Therapeutic Peptide APIs Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Therapeutic Peptide APIs Growth Accelerators and Market Barriers
Table 45. Southeast Asia Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Therapeutic Peptide APIs Investment Opportunities and Key Challenges
Table 47. Central and South America Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Therapeutic Peptide APIs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Therapeutic Peptide APIs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bachem Corporation Information
Table 51. Bachem Description and Major Businesses
Table 52. Bachem Product Models, Descriptions and Specifications
Table 53. Bachem Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 54. Bachem Sales Value Proportion by Product in 2024
Table 55. Bachem Sales Value Proportion by Application in 2024
Table 56. Bachem Sales Value Proportion by Geographic Area in 2024
Table 57. Bachem Therapeutic Peptide APIs SWOT Analysis
Table 58. Bachem Recent Developments
Table 59. GenScript Corporation Information
Table 60. GenScript Description and Major Businesses
Table 61. GenScript Product Models, Descriptions and Specifications
Table 62. GenScript Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 63. GenScript Sales Value Proportion by Product in 2024
Table 64. GenScript Sales Value Proportion by Application in 2024
Table 65. GenScript Sales Value Proportion by Geographic Area in 2024
Table 66. GenScript Therapeutic Peptide APIs SWOT Analysis
Table 67. GenScript Recent Developments
Table 68. AmbioPharm Corporation Information
Table 69. AmbioPharm Description and Major Businesses
Table 70. AmbioPharm Product Models, Descriptions and Specifications
Table 71. AmbioPharm Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 72. AmbioPharm Sales Value Proportion by Product in 2024
Table 73. AmbioPharm Sales Value Proportion by Application in 2024
Table 74. AmbioPharm Sales Value Proportion by Geographic Area in 2024
Table 75. AmbioPharm Therapeutic Peptide APIs SWOT Analysis
Table 76. AmbioPharm Recent Developments
Table 77. Limitless Biotech Corporation Information
Table 78. Limitless Biotech Description and Major Businesses
Table 79. Limitless Biotech Product Models, Descriptions and Specifications
Table 80. Limitless Biotech Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Limitless Biotech Sales Value Proportion by Product in 2024
Table 82. Limitless Biotech Sales Value Proportion by Application in 2024
Table 83. Limitless Biotech Sales Value Proportion by Geographic Area in 2024
Table 84. Limitless Biotech Therapeutic Peptide APIs SWOT Analysis
Table 85. Limitless Biotech Recent Developments
Table 86. CPC Scientific Corporation Information
Table 87. CPC Scientific Description and Major Businesses
Table 88. CPC Scientific Product Models, Descriptions and Specifications
Table 89. CPC Scientific Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. CPC Scientific Sales Value Proportion by Product in 2024
Table 91. CPC Scientific Sales Value Proportion by Application in 2024
Table 92. CPC Scientific Sales Value Proportion by Geographic Area in 2024
Table 93. CPC Scientific Therapeutic Peptide APIs SWOT Analysis
Table 94. CPC Scientific Recent Developments
Table 95. PolyPeptide Corporation Information
Table 96. PolyPeptide Description and Major Businesses
Table 97. PolyPeptide Product Models, Descriptions and Specifications
Table 98. PolyPeptide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 99. PolyPeptide Recent Developments
Table 100. CordenPharma Corporation Information
Table 101. CordenPharma Description and Major Businesses
Table 102. CordenPharma Product Models, Descriptions and Specifications
Table 103. CordenPharma Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 104. CordenPharma Recent Developments
Table 105. Lonza Corporation Information
Table 106. Lonza Description and Major Businesses
Table 107. Lonza Product Models, Descriptions and Specifications
Table 108. Lonza Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 109. Lonza Recent Developments
Table 110. Aspen API Corporation Information
Table 111. Aspen API Description and Major Businesses
Table 112. Aspen API Product Models, Descriptions and Specifications
Table 113. Aspen API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 114. Aspen API Recent Developments
Table 115. Syngene Corporation Information
Table 116. Syngene Description and Major Businesses
Table 117. Syngene Product Models, Descriptions and Specifications
Table 118. Syngene Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 119. Syngene Recent Developments
Table 120. USV Peptides Corporation Information
Table 121. USV Peptides Description and Major Businesses
Table 122. USV Peptides Product Models, Descriptions and Specifications
Table 123. USV Peptides Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 124. USV Peptides Recent Developments
Table 125. Bio Basic Corporation Information
Table 126. Bio Basic Description and Major Businesses
Table 127. Bio Basic Product Models, Descriptions and Specifications
Table 128. Bio Basic Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 129. Bio Basic Recent Developments
Table 130. JPT Peptide Technologies Corporation Information
Table 131. JPT Peptide Technologies Description and Major Businesses
Table 132. JPT Peptide Technologies Product Models, Descriptions and Specifications
Table 133. JPT Peptide Technologies Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 134. JPT Peptide Technologies Recent Developments
Table 135. ScinoPharm Corporation Information
Table 136. ScinoPharm Description and Major Businesses
Table 137. ScinoPharm Product Models, Descriptions and Specifications
Table 138. ScinoPharm Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 139. ScinoPharm Recent Developments
Table 140. Piramal Pharma Corporation Information
Table 141. Piramal Pharma Description and Major Businesses
Table 142. Piramal Pharma Product Models, Descriptions and Specifications
Table 143. Piramal Pharma Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 144. Piramal Pharma Recent Developments
Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Corporation Information
Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Major Businesses
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Product Models, Descriptions and Specifications
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments
Table 150. Cheng Du Sheng Nuo Biotec Corporation Information
Table 151. Cheng Du Sheng Nuo Biotec Description and Major Businesses
Table 152. Cheng Du Sheng Nuo Biotec Product Models, Descriptions and Specifications
Table 153. Cheng Du Sheng Nuo Biotec Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 154. Cheng Du Sheng Nuo Biotec Recent Developments
Table 155. Hybio Pharmaceutical Corporation Information
Table 156. Hybio Pharmaceutical Description and Major Businesses
Table 157. Hybio Pharmaceutical Product Models, Descriptions and Specifications
Table 158. Hybio Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 159. Hybio Pharmaceutical Recent Developments
Table 160. Hainan Shuangcheng Pharmaceuticals Corporation Information
Table 161. Hainan Shuangcheng Pharmaceuticals Description and Major Businesses
Table 162. Hainan Shuangcheng Pharmaceuticals Product Models, Descriptions and Specifications
Table 163. Hainan Shuangcheng Pharmaceuticals Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments
Table 165. Guangdong Jianyuan Pharmaceutical Corporation Information
Table 166. Guangdong Jianyuan Pharmaceutical Description and Major Businesses
Table 167. Guangdong Jianyuan Pharmaceutical Product Models, Descriptions and Specifications
Table 168. Guangdong Jianyuan Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 169. Guangdong Jianyuan Pharmaceutical Recent Developments
Table 170. Zhejiang Peptites Biotech Corporation Information
Table 171. Zhejiang Peptites Biotech Description and Major Businesses
Table 172. Zhejiang Peptites Biotech Product Models, Descriptions and Specifications
Table 173. Zhejiang Peptites Biotech Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 174. Zhejiang Peptites Biotech Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Peptide APIs Product Picture
Figure 2. Global Therapeutic Peptide APIs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bioactive Peptides Product Picture
Figure 4. Synthetic Peptides Product Picture
Figure 5. Global Therapeutic Peptide APIs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceuticals
Figure 7. Scientific Research
Figure 8. Other
Figure 9. Therapeutic Peptide APIs Report Years Considered
Figure 10. Global Therapeutic Peptide APIs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 12. Global Therapeutic Peptide APIs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Therapeutic Peptide APIs Revenue Market Share by Region (2020-2031)
Figure 14. Global Therapeutic Peptide APIs Sales (2020-2031) & (Tons)
Figure 15. Global Therapeutic Peptide APIs Sales (CAGR) by Region (2020-2031) (Tons)
Figure 16. Global Therapeutic Peptide APIs Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Therapeutic Peptide APIs Sales Volume Market Share in 2024
Figure 18. Global Therapeutic Peptide APIs Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Bioactive Peptides Revenue Market Share by Manufacturer in 2024
Figure 21. Synthetic Peptides Revenue Market Share by Manufacturer in 2024
Figure 22. Global Therapeutic Peptide APIs Sales Market Share by Type (2020-2031)
Figure 23. Global Therapeutic Peptide APIs Revenue Market Share by Type (2020-2031)
Figure 24. Global Therapeutic Peptide APIs Sales Market Share by Application (2020-2031)
Figure 25. Global Therapeutic Peptide APIs Revenue Market Share by Application (2020-2031)
Figure 26. North America Therapeutic Peptide APIs Sales YoY (2020-2031) & (Tons)
Figure 27. North America Therapeutic Peptide APIs Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Therapeutic Peptide APIs Sales Revenue (US$ Million) in 2024
Figure 29. North America Therapeutic Peptide APIs Sales Volume (Tons) by Type (2020- 2031)
Figure 30. North America Therapeutic Peptide APIs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Therapeutic Peptide APIs Sales Volume (Tons) by Application (2020-2031)
Figure 32. North America Therapeutic Peptide APIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Therapeutic Peptide APIs Sales YoY (2020-2031) & (Tons)
Figure 37. Europe Therapeutic Peptide APIs Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Therapeutic Peptide APIs Sales Revenue (US$ Million) in 2024
Figure 39. Europe Therapeutic Peptide APIs Sales Volume (Tons) by Type (2020-2031)
Figure 40. Europe Therapeutic Peptide APIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Therapeutic Peptide APIs Sales Volume (Tons) by Application (2020-2031)
Figure 42. Europe Therapeutic Peptide APIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 44. France Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Therapeutic Peptide APIs Sales YoY (2020-2031) & (Tons)
Figure 49. Asia-Pacific Therapeutic Peptide APIs Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Therapeutic Peptide APIs Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Therapeutic Peptide APIs Sales Volume (Tons) by Type (2020- 2031)
Figure 52. Asia-Pacific Therapeutic Peptide APIs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Therapeutic Peptide APIs Sales Volume (Tons) by Application (2020-2031)
Figure 54. Asia-Pacific Therapeutic Peptide APIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 59. India Therapeutic Peptide APIs Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Therapeutic Peptide APIs Sales YoY (2020-2031) & (Tons)
Figure 61. Central and South America Therapeutic Peptide APIs Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Therapeutic Peptide APIs Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Therapeutic Peptide APIs Sales Volume (Tons) by Type (2021-2031)
Figure 64. Central and South America Therapeutic Peptide APIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Therapeutic Peptide APIs Sales Volume (Tons) by Application (2020-2031)
Figure 66. Central and South America Therapeutic Peptide APIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Therapeutic Peptide APIs Sales YoY (2020-2031) & (Tons)
Figure 70. Middle East and Africa Therapeutic Peptide APIs Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Therapeutic Peptide APIs Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Therapeutic Peptide APIs Sales Volume (Tons) by Type (2021-2031)
Figure 73. South America Therapeutic Peptide APIs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Therapeutic Peptide APIs Sales Volume (Tons) by Application (2020-2031)
Figure 75. Middle East and Africa Therapeutic Peptide APIs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Therapeutic Peptide APIs Revenue (2020-2025) & (US$ Million)
Figure 80. Therapeutic Peptide APIs Industry Chain Mapping
Figure 81. Regional Therapeutic Peptide APIs Manufacturing Base Distribution (%)
Figure 82. Global Therapeutic Peptide APIs Production Market Share by Region (2020-2031)
Figure 83. Therapeutic Peptide APIs Production Process
Figure 84. Regional Therapeutic Peptide APIs Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
